$91.4 Million is the total value of 72 Investment Holdings, LLC's 6 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXDX | PROMETHEUS BIOSCIENCES INC | $69,781,000 | -4.5% | 1,848,024 | 0.0% | 76.33% | +17.7% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $10,098,000 | -48.2% | 988,995 | 0.0% | 11.05% | -36.1% | |
| Sell | ENTRADA THERAPEUTICS INC | $4,780,000 | -45.1% | 509,023 | -0.0% | 5.23% | -32.4% | |
| CARIBOU BIOSCIENCES INC | $4,352,000 | -39.2% | 474,067 | 0.0% | 4.76% | -25.0% | ||
| OMEGA THERAPEUTICS INC | $2,202,000 | -44.9% | 352,941 | 0.0% | 2.41% | -32.1% | ||
| WEWORK INCcl a | $204,000 | -20.9% | 29,978 | 0.0% | 0.22% | -2.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | 12 | Q3 2023 | 49.0% |
| PROMETHEUS BIOSCIENCES INC | 9 | Q1 2023 | 93.9% |
| CARIBOU BIOSCIENCES INC | 9 | Q3 2023 | 15.7% |
| OMEGA THERAPEUTICS INC | 9 | Q3 2023 | 15.4% |
| ENTRADA THERAPTEUTICS INC | 8 | Q3 2023 | 60.0% |
| WEWORK INC | 2 | Q1 2022 | 0.2% |
| PALANTIR TECHNOLOGIES INC | 1 | Q4 2020 | 92.7% |
| TURNSTONE BIOLOGICS CORP | 1 | Q3 2023 | 14.5% |
View 72 Investment Holdings, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View 72 Investment Holdings, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.